Relay Therapeutics Announces Pricing of Public Offering of Common Stock
Relay Therapeutics priced a public offering of 22.9 million shares at $12.00 per share, raising approximately $275 million in gross proceeds. The company granted underwriters a 30-day option to purchase up to 3.4 million additional shares. Jefferies, TD Cowen, Goldman Sachs, and Guggenheim acted as joint book-runners.
Key figures
- Deal Value Usd
- 275000000
- Offering Price
- 12
- Shares Offered
- 22916667
- Overallotment shares
- 3437500
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.